Cross-Talk Between VEGF and BMP-6 Pathways Accelerates Osteogenic Differentiation of Human Adipose-Derived Stem Cells

Journal of Cellular Physiology

Volumn 230, Issue 11, 2015, Pages 2671-2682

  Li, Ching Ju ^a   Madhu, Vedavathi ^a   Balian, Gary ^a   Dighe, Abhijit S ^a   Cui, Quanjun ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BONE MORPHOGENETIC PROTEIN 6; COLLAGEN TYPE 1; COLLAGEN TYPE 1 A2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VASCULOTROPIN; BMP6 PROTEIN, HUMAN; COL1A2 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADIPOSE DERIVED STEM CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MINERALIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ADIPOCYTE; BIOSYNTHESIS; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOBLAST;

ADIPOCYTES; BONE MORPHOGENETIC PROTEIN 6; CELL DIFFERENTIATION; COLLAGEN TYPE I; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOGENESIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84937952647     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24983     Document Type: Article

References (55)

1. Bajada S, Marshall MJ, Wright KT, Richardson JB, Johnson WE. 2009. Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 secretion in human fracture non union stromal cells. Bone 45:726-735.
2. Choi YH, Jeong HM, Jin YH, Li H, Yeo CY, Lee KY. 2011. Akt phosphorylates and regulates the osteogenic activity of Osterix. Biochem Biophys Res Commun 411:637-641.
3. Cui F, Wang X, Liu X, Dighe AS, Balian G, Cui Q. 2010. VEGF and BMP-6 enhance bone formation mediated by cloned mouse osteoprogenitor cells. Growth Factors 28:306-317.
4. Cui Q, Dighe AS, Irvine JN. 2013. Combined angiogenic and osteogenic factor delivery for bone regenerative engineering. Curr Pharm Des 19:3374-3383.
5. Das A, Fishero B, Jared CJ, Li C.-J, Kohli N, Lin Y, Dighe AS, Cui Q. 2014. Poly(lactic-co-glycolide) polymer constructs cross-linked with human BMP-6 and VEGF protein significantly enhances rat mandible defect repair.
6. Domingues I, Rino J, Demmers JA, de Lanerolle P, Santos SC. 2011. VEGFR2 translocates to the nucleus to regulate its own transcription. PLoS One 6:e25668.
7. Du L, Yang P, Ge S. 2012. Stromal cell-derived factor-1 significantly induces proliferation, migration and collagen type i expression in a human periodontal ligament stem cell subpopulation. J Periodontol 83:379-388.
8. Fajardo M, Liu CJ, Egol K. 2009. Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: A pilot study. Clin Orthop Relat Res 467:3071-3078.
9. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, Sessa WC. 2001. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 276:30359-30365.
10. Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, Lotinun S, Sano Y, Baron R, Park JM, Arthur S, Xie M, Schneider MD, Zhai B, Gygi S, Davis R, Glimcher LH. 2010. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest 120:2457-2473.
11. Hager S, Lampert FM, Orimo H, Stark GB, Finkenzeller G. 2009. Up-regulation of alkaline phosphatase expression in human primary osteoblasts by cocultivation with primary endothelial cells is mediated by p38 mitogen-activated protein kinase-dependent mRNA stabilization. Tissue Eng Part A 15:3437-3447.
12. Hausman MR, Schaffler MB, Majeska RJ. 2001. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 29:560-564.
13. Jeong HM, Jin YH, Kim YJ, Yum J, Choi YH, Yeo CY, Lee KY. 2011. Akt phosphorylates and regulates the function of Dlx5. Biochem Biophys Res Commun 409:681-686.
14. Kang H, Chang W, Hurley M, Vignery A, Wu D. 2010. Important roles of PI3Kgamma in osteoclastogenesis and bone homeostasis. Proc Natl Acad Sci USA 107:12901-12906.
15. Kloen P, Lauzier D, Hamdy RC. 2012. Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions. Bone 51:59-68.
16. Kubo M, Imai S, Fujimiya M, Isoya E, Ando K, Mimura T, Matsusue Y. 2007. Exogenous collagen-enhanced recruitment of mesenchymal stem cells during rabbit articular cartilage repair. Acta Orthop 78:845-855.
17. Kubota K, Iseki S, Kuroda S, Oida S, Iimura T, Duarte WR, Ohya K, Ishikawa I, Kasugai S. 2002. Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 31:465-471.
18. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. 2003. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 309:689-694.
19. Lee KW, Yook JY, Son MY, Kim MJ, Koo DB, Han YM, Cho YS. 2010. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway. Stem Cells Dev 19:557-568.
20. Li G, Corsi-Payne K, Zheng B, Usas A, Peng H, Huard J. 2009. The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A. 15:2123-2133.
21. Li X, Su G, Wang J, Zhou Z, Li L, Liu L, Guan M, Zhang Q, Wang H. 2013. Exogenous bFGF promotes articular cartilage repair via up-regulation of multiple growth factors. Osteoarthritis Cartilage 21:1567-1575.
22. Liu X, Bruxvoort KJ, Zylstra CR, Liu J, Cichowski R, Faugere MC, Bouxsein ML, Wan C, Williams BO, Clemens TL. 2007. Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc Natl Acad Sci USA 104:2259-2264.
23. Liu Y, Berendsen AD, Jia S, Lotinun S, Baron R, Ferrara N, Olsen BR. 2012. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest 122:3101-3113.
24. + mouse bone marrow derived osteoprogenitor cells respond to combination of VEGF and BMP-6 to display enhanced osteoblastic differentiation and ectopic bone formation. PLoS One 9:e103060.
25. Mathieu M, Rigutto S, Ingels A, Spruyt D, Stricwant N, Kharroubi I, Albarani V, Jayankura M, Rasschaert J, Bastianelli E, Gangji V. 2013. Decreased pool of mesenchymal stem cells is associated with altered chemokines serum levels in atrophic nonunion fractures. Bone 53:391-398.
26. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T. 2008. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283:29119-29125.
27. Mauney J, Olsen BR, Volloch V. 2010. Matrix remodeling as stem cell recruitment event: a novel in vitro model for homing of human bone marrow stromal cells to the site of injury shows crucial role of extracellular collagen matrix. Matrix Biol 29:657-663.
28. Mukherjee A, Rotwein P. 2012. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development. Mol Cell Biol 32:490-500.
29. Mukherjee A, Wilson EM, Rotwein P. 2010. Selective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation. Mol Cell Biol 30:1018-1027.
30. Niikura T, Hak DJ, Reddi AH. 2006. Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures. J Orthop Res 24:1463-1471.
31. Ortuño MJ, Ruiz-Gaspà S, Rodríguez-Carballo E, Susperregui AR, Bartrons R, Rosa JL, Ventura F. 2010. p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix. J Biol Chem 285:31985-31994.
32. Payne KA, Meszaros LB, Phillippi JA, Huard J. 2010. Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells. Tissue Eng Part A 16:3647-3655.
33. Peng H, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, Huard J. 2005. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20:2017-2027.
34. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J. 2002. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110:751-719.
35. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N. 2003. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17:1352-1365.
36. Roldán JC, Detsch R, Schaefer S, Chang E, Kelantan M, Waiss W, Reichert TE, Gurtner GC, Deisinger U. 2010. Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model. J Craniomaxillofac Surg 38:423-430.
37. Schmidmaier G, Wildemann B, Gäbelein T, Heeger J, Kandziora F, Haas NP, Raschke M. 2003. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand 74:604-610.
38. Seamon J, Wang X, Cui F, Keller T, Dighe AS, Balian G, Cui Q. 2013. Adenoviral delivery of the VEGF and BMP-6 genes to rat mesenchymal stem cells potentiates osteogenesis. Bone Marrow Res 2013:737580.
39. Shi S, Mercer S, Eckert GJ, Trippel SB. 2009. Growth factor regulation of growth factors in articular chondrocytes. J Biol Chem 284:6697-6704.
40. Simon BR, Parlee SD, Learman BS, Mori H, Scheller EL, Cawthorn WP, Ning X, Gallagher K, Tyrberg B, Assadi-Porter FM, Evans CR, MacDougald OA. 2013. Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptors. J Biol Chem 288:32475-32489.
41. Song K, Rao NJ, Chen ML, Huang ZJ, Cao YG. 2011. Enhanced bone regeneration with sequential delivery of basic fibroblast growth factor and sonic hedgehog. Injury 42:796-802.
42. Street J, Bao M, deGuzman L, Bunting S, Peale FV, Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661.
43. Thibault MM, Hoemann CD, Buschmann MD. 2007. Fibronectin, vitronectin, and collagen I induce chemotaxis and haptotaxis of human and rabbit mesenchymal stem cells in a standardized transmembrane assay. Stem Cells Dev 16:489-502.
44. Thouverey C, Caverzasio J. 2012. The p38α MAPK positively regulates osteoblast function and postnatal bone acquisition. Cell Mol Life Sci 69:3115-3125.
45. Ulici V, Hoenselaar KD, Agoston H, McErlain DD, Umoh J, Chakrabarti S, Holdsworth DW, Beier F. 2009. The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. Bone 45:1133-1145.
46. Wang X, Cui F, Madhu V, Dighe AS, Balian G, Cui Q. 2011. Combined VEGF and LMP-1 delivery enhances osteoprogenitor cell differentiation and ectopic bone formation. Growth Factors 29:36-48.
47. Wang X, Goh CH, Li B. 2007. P38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. Endocrinology 148:1629-1637.
48. Wutzl A, Rauner M, Seemann R, Millesi W, Krepler P, Pietschmann P, Ewers R. 2010. Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. J Orthop Res 28:1431-1439.
49. Xu DJ, Zhao YZ, Wang J, He JW, Weng YG, Luo JY. 2010. Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. BMB Rep 45:247-252.
50. Yano H, Hamanaka R, Nakamura-Ota M, Adachi S, Zhang JJ, Matsuo N, Yoshioka H. 2014. Sp7/Osterix induces the mouse pro-α2 (I) collagen gene (Col1a2) expression via the proximal promoter in osteoblastic cells. Biochem Biophys Res Commun 452:531-536.
51. Yoshiga D, Sato N, Torisu T, Mori H, Yoshida R, Nakamura S, Takaesu G, Kobayashi T, Yoshimura A. 2007. Adaptor protein SH2-B linking receptor-tyrosine kinase and Akt promotes adipocyte differentiation by regulating peroxisome proliferator-activated receptor gamma messenger ribonucleic acid levels. Mol Endocrinol 21:1120-1131.
52. Zhang Y, Madhu V, Dighe AS, Irvine JN, Jr, Cui Q. 2012. Osteogenic response of human adipose-derived stem cells to BMP-6, VEGF, and combined VEGF plus BMP-6 in vitro. Growth Factors 30:333-343.
53. Zhao Y, Song T, Wang W, Wang J, He J, Wu N, Tang M, He B, Luo J. 2012. P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One 7:e43383.
54. Zhou FH, Foster BK, Zhou XF, Cowin AJ, Xian CJ. 2006. TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res 21:1075-1088.
55. Zhu F, Friedman MS, Luo W, Woolf P, Hankenson KD. 2012. The transcription factor osterix (SP7) regulates BMP6-induced human osteoblast differentiation. J Cell Physiol 227:2677-2685.